Holen Sie sich die Stockscreener-App
60.38
10.34%
-6.96
Monopar Therapeutics Inc Aktie (MNPR) Neueste Nachrichten
Bull Bear: Why is Monopar Therapeutics Inc stock going down2025 Dividend Review & Advanced Technical Analysis Signals - baoquankhu1.vn
Monopar Therapeutics (NASDAQ:MNPR) Given Buy Rating at Chardan Capital - Defense World
Chardan Capital Reaffirms Buy Rating on MNPR with $100 Price Tar - GuruFocus
Chardan Capital Reaffirms Buy Rating for Monopar Therapeutics (NASDAQ:MNPR) - MarketBeat
Precision Trading with Monopar Therapeutics Inc. (MNPR) Risk Zones - Stock Traders Daily
Breakout Move: Will Monopar Therapeutics Inc outperform tech stocksStop Loss & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Market Leaders: Will Monopar Therapeutics Inc outperform tech stocksMarket Rally & Growth Focused Entry Reports - baoquankhu1.vn
JonesTrading Maintains Monopar Therapeutics(MNPR.US) With Buy Rating, Maintains Target Price $130 - 富途牛牛
Monopar Therapeutics stock rating reiterated by Cantor Fitzgerald - Investing.com Canada
Monopar Therapeutics: Tiny Cancer-Drug Stock Caught Between Speculation And Survival - AD HOC NEWS
Monopar Therapeutics Inc. (NASDAQ:MNPR) Short Interest Up 28.3% in December - MarketBeat
Fundamentals Check: Why is Monopar Therapeutics Inc stock going downJuly 2025 Recap & Trade Opportunity Analysis Reports - baoquankhu1.vn
Technical Reactions to MNPR Trends in Macro Strategies - Stock Traders Daily
Price Action: Is Monopar Therapeutics Inc impacted by rising rates2025 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn
History Review: Is CO2 Energy Transition Corp a stock for growth or value investors2025 Geopolitical Influence & High Win Rate Trade Tips - baoquankhu1.vn
BTIG Reiterates Buy Rating for MNPR with $104 Target Price | MNP - GuruFocus
Monopar Therapeutics' (MNPR) "Buy" Rating Reiterated at BTIG Research - MarketBeat
3 ‘Strong Buy’ Stocks to Buy Today, 1/14/2026, According to Top Analysts - TipRanks
BTIG reiterates Buy rating on Monopar Therapeutics stock ahead of NDA submission - Investing.com Canada
Momentum Shift: How strong is Monopar Therapeutics Inc stock balance sheetMarket Volume Summary & Technical Entry and Exit Alerts - Bộ Nội Vụ
Aug Closing: Is Monopar Therapeutics Inc. stock a safe investment in uncertain marketsWeekly Earnings Recap & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
Sentiment Recap: Is Monopar Therapeutics Inc. stock a safe haven assetInflation Watch & Reliable Intraday Trade Alerts - Bộ Nội Vụ
CEO Moves: How cyclical is Monopar Therapeutics Inc. (1IY0) stock compared to rivals2025 Institutional Moves & Daily Market Momentum Tracking - Bộ Nội Vụ
How dovish Fed policy supports Monopar Therapeutics Inc. (1IY0) stock2025 Market WrapUp & Weekly Watchlist for Hot Stocks - Улправда
Monopar Therapeutics (NASDAQ:MNPR) Rating Lowered to "Sell" at Wall Street Zen - MarketBeat
Monopar Therapeutics (NASDAQ:MNPR) Rating Lowered to “Sell” at Wall Street Zen - Defense World
Monopar Therapeutics initiated with an Overweight at Morgan Stanley - TipRanks
Morgan Stanley Initiates Coverage on Monopar Therapeutics (MNPR) - GuruFocus
Morgan Stanley initiates Monopar Therapeutics stock with Overweight rating By Investing.com - Investing.com Canada
Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Average Rating of “Buy” from Brokerages - Defense World
Why Monopar Therapeutics Inc. stock appeals to analystsPrice Action & Daily Growth Stock Tips - ulpravda.ru
Can Monopar Therapeutics Inc. stock maintain operating marginsTrade Exit Report & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
How risky is Monopar Therapeutics Inc. stock nowWeekly Investment Recap & Free Community Consensus Stock Picks - Улправда
symbol__ Stock Quote Price and Forecast - CNN
Will Monopar Therapeutics Inc. stock return to pre crisis levelsJuly 2025 News Drivers & Fast Moving Stock Watchlists - Улправда
Can Monopar Therapeutics Inc. stock hit record highs again2025 Macro Impact & Weekly Return Optimization Alerts - Улправда
Published on: 2026-01-09 02:26:30 - ulpravda.ru
Published on: 2026-01-09 02:04:15 - Улправда
Will Monopar Therapeutics Inc. stock keep outperforming rivalsEntry Point & Low Risk Investment Opportunities - Улправда
Will Monopar Therapeutics Inc. stock gain from strong economyWeekly Trade Analysis & Capital Efficient Trade Techniques - ulpravda.ru
Published on: 2026-01-09 00:02:11 - ulpravda.ru
Published on: 2026-01-08 22:24:28 - Улправда
Trading the Move, Not the Narrative: (MNPR) Edition - Stock Traders Daily
EPS Watch: What dividend safety score for Monopar Therapeutics Inc. stock2025 Momentum Check & Verified Swing Trading Watchlists - Bộ Nội Vụ
Monopar Therapeutics announces pricing of $135M offering - MSN
Aug Gainers: Why Monopar Therapeutics Inc stock appeals to analystsProfit Target & Fast Momentum Stock Entry Tips - moha.gov.vn
Hedge Fund Moves: Is Monopar Therapeutics Inc stock a buy for dividend growthSwing Trade & Technical Entry and Exit Alerts - moha.gov.vn
Top Executive Makes Bold Insider Move at Monopar Therapeutics - TipRanks
Insider Buying: Quan Vu Acquires Shares of Monopar Therapeutics Inc (MNPR) - GuruFocus
Monopar Therapeutics (NASDAQ:MNPR) CFO Purchases 1,500 Shares - MarketBeat
Monopar therapeutics CFO Vu Quan Anh buys $104925 in shares By Investing.com - Investing.com Canada
Monopar Therapeutics (NASDAQ:MNPR) Sharpens Focus on Molecular Targeting - Kalkine Media
Wall Street Analysts Predict a 51.26% Upside in Monopar Therapeutics (MNPR): Here's What You Should Know - MSN
Monopar Therapeutics Inc. (NASDAQ:MNPR) Short Interest Update - MarketBeat
Responsive Playbooks and the MNPR Inflection - Stock Traders Daily
What Awaits These 4 Biotech Stocks That More Than Doubled in 2025 - Zacks Investment Research
Independent Director Arthur Klausner Sold A Bunch Of Shares In Monopar Therapeutics - simplywall.st
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):